Clinical Trial Update: Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Xaliproden for recovery from severe neuropathy after oxaliplatin-based adjuvant chemotherapy in colorectal cancer patients; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xaliproden (Xaliproden)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Neoplasms | Phase 3 | Status: TERMINATED